Seasoned investor and entrepreneur with multi-asset experience across private equity, distressed and alternative credit strategies, focused on value-oriented deal sourcing and operational turnarounds. Richard Zipkis has founded and led investment vehicles, advised on capital raises and structured exits, and frequently serves on board and investment committees to drive governance and performance. Known for cross-border transaction execution, portfolio optimization and LP relationships, with a market-oriented approach to risk-adjusted returns.
Seasoned investor and entrepreneur with multi-asset experience across private equity, distressed and alternative credit strategies, focused on value-oriented deal sourcing and operational turnarounds. Richard Zipkis has founded and led investment vehicles, advised on capital raises and structured exits, and frequently serves on board and investment committees to drive governance and performance. Known for cross-border transaction execution, portfolio optimization and LP relationships, with a market-oriented approach to risk-adjusted returns.
Combines value-oriented, multi-asset investing with a bias toward distressed and alternative credit opportunities where operational intervention can unlock returns. Prioritizes deep due diligence, conservative capital structuring, active board-level governance and phased value-creation plans to de-risk deals. Favors cross-border situations and complex restructurings, targeting asymmetric, risk-adjusted returns over medium-term horizons while maintaining LP alignment and exit discipline.
Combines value-oriented, multi-asset investing with a bias toward distressed and alternative credit opportunities where operational intervention can unlock returns. Prioritizes deep due diligence, conservative capital structuring, active board-level governance and phased value-creation plans to de-risk deals. Favors cross-border situations and complex restructurings, targeting asymmetric, risk-adjusted returns over medium-term horizons while maintaining LP alignment and exit discipline.
| Trades 656 | Longs Won 524/656 79% | Profit Factor 10.17 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $324,638.98 |
| Average Win $96,120.19 | Best Trade (Sep 01) $7.62M | Sharpe Ratio -13.37 |
| Average Loss -$37,514.78 | Worst Trade (Aug 02) -$909,007.69 | Z-Score 6.52 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 1d | Expectancy $69,230.23 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,673 | 4,206 | 3,738 | 3,271 | 2,804 | 2,336 | 1,869 | 1,402 | 935 | 467 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 15,082 | $2.94M | $4.66M | - | $1.72M | 58.46% | -7.354% |
ABBV AbbVie Inc. | 3,947 | $628,122.85 | $990,460.18 | - | $362,337.33 | 57.69% | -2.513% |
ABT Abbott Laboratories | 5,949 | $539,812 | $628,809.3 | - | $88,997.3 | 16.49% | +0.085% |
ACGL Arch Capital Group Ltd | 2,777 | $206,247.79 | $279,171.81 | - | $72,924.02 | 35.36% | -0.603% |
ACN Accenture plc Class A | 2,167 | $427,549.25 | $359,548.64 | - | -$68,000.61 | -15.9% | +1.611% |
ADP Automatic Data Processing Inc. | 8,558 | $1.83M | $2.28M | - | $454,944.49 | 24.92% | +0.982% |
AEP American Electric Power Company, Inc. | 22,047 | $1.9M | $2.82M | - | $921,596.35 | 48.58% | +0.055% |
AIQ Global X Artificial Intelligence & Technology ETF | 24,200 | $1.14M | $1.43M | - | $285,472 | 25.05% | +0.341% |
AMD Advanced Micro Devices, Inc. | 1,710 | $380,883.4 | $814,216.48 | - | $433,333.08 | 113.77% | -1.904% |
AMGN Amgen Inc. | 8,754 | $2.46M | $3.37M | - | $911,008.79 | 37.02% | -0.64% |
AMLP Alerian MLP ETF | 22,593 | $962,237.46 | $1.25M | - | $287,607.3 | 29.89% | +0.894% |
AMZN Amazon.com Inc | 4,022 | $611,102.68 | $1.09M | - | $481,192.04 | 78.74% | +15.321% |
ANET Arista Networks, Inc. | 2,400 | $245,587.4 | $432,840.02 | - | $187,252.62 | 76.25% | +5.456% |
AON Aon plc | 682 | $198,475.64 | $245,895.09 | - | $47,419.45 | 23.89% | -1.642% |
ASML ASML Holding N.V. New York Registry Shares | 424 | $336,371.87 | $690,696 | - | $354,324.13 | 105.34% | -1.359% |
AVGO Broadcom Inc. | 1,948 | $252,849.2 | $758,317.44 | - | $505,468.24 | 199.91% | +0.371% |
AZN AstraZeneca PLC American Depositary Shares | 1,430 | $271,157 | $242,585.2 | - | -$28,571.8 | -10.54% | -0.992% |
BNY BlackRock New York Municipal Income Trust | 12,496 | $650,416.8 | $1.95M | - | $1.3M | 200.35% | +0.16% |
BRK-B Berkshire Hathaway Inc. | 1,073 | $406,916.22 | $548,882.42 | - | $141,966.2 | 34.89% | +0.365% |
BX Blackstone Inc. | 6,041 | $710,844 | $771,737.75 | - | $60,893.75 | 8.57% | -0.25% |